Pirchio R, Graziadio C, Colao A, Pivonello R, Auriemma RS.
Front Endocrinol (Lausanne). 2022 Sep 27;13:1015520. doi: 10.3389/fendo.2022.1015520. eCollection 2022.
PMID:36237192
Pharmacological Causes of Hyperprolactinemia.
Kolnikaj TS, Musat M, Salehidoost R, Korbonits M.
2024 Jan 4. In: Feingold KR, Ahmed SF, Anawalt B, Blackman MR, Boyce A, Chrousos G, Corpas E, de Herder WW, Dhatariya K, Dungan K, Hofland J, Kalra S, Kaltsas G, Kapoor N, Koch C, Kopp P, Korbonits M, Kovacs CS, Kuohung W, Laferrère B, Levy M, McGee EA, McLachlan R, Muzumdar R, Purnell J, Rey R, Sahay R, Shah AS, Singer F, Sperling MA, Stratakis CA, Trence DL, Wilson DP, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000–.
PMID:38198581
Neuroleptic-induced hyperprolactinemia.
Dickson RA, Glazer WM.
Schizophr Res. 1999 Mar 1;35 Suppl:S75-86. doi: 10.1016/s0920-9964(98)00159-5.
PMID:10190228
Stress-Induced Hyperprolactinemia: Pathophysiology and Clinical Approach.
Levine S, Muneyyirci-Delale O.
Obstet Gynecol Int. 2018 Dec 3;2018:9253083. doi: 10.1155/2018/9253083. eCollection 2018.
PMID:30627169
Sexual function in altered physiological states: comparison of effects of hypertension, diabetes, hyperprolactinemia, and others to "normal" aging in male rats.